ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

DARE Dare Bioscience Inc

0.286
0.00 (0.00%)
Apr 24 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Dare Bioscience Inc DARE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.286 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.286
more quote information »

Recent News

Date Time Source Heading
4/23/202408:00GLOBEDaré Bioscience Announces Grant Funding Installment to..
4/11/202408:00GLOBEDaré Bioscience Announces Publication in Contraception of..
3/28/202408:00GLOBEDaré Bioscience Reports Full Year 2023 Financial Results and..
3/28/202407:42IHMARKETNEWSUS Stock Futures Stable in Pre-Market On Path for..
3/21/202408:00GLOBEDaré Bioscience to Host Full Year 2023 Financial Results and..
2/22/202408:00GLOBEDaré Bioscience to Present at the International Society for..
1/31/202408:00GLOBEDaré Bioscience Announces Positive End-of-Phase 2 Meeting..
1/29/202416:18EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/26/202417:15EDGAR2Form 8-K - Current report
1/26/202416:30GLOBEDaré Bioscience Announces Executive Team and Board of..
1/19/202416:30EDGAR2Form 8-K - Current report
1/17/202408:00GLOBEDaré Bioscience Announces Grant to Support Biotherapeutic..
1/08/202408:00EDGAR2Form 8-K - Current report
1/04/202408:00GLOBEDaré Bioscience’s DARE-LARC1 Platform Technology Achieves..
12/26/202308:05EDGAR2Form 8-K - Current report
12/26/202308:00GLOBEDaré Bioscience Secures $12 million in Royalty-backed..
12/20/202308:05EDGAR2Form 8-K - Current report
12/20/202308:00GLOBEDaré Bioscience Announces Positive Topline Pharmacokinetic..
12/13/202308:00GLOBEDaré Bioscience Announces Funding Award Notice from the..
12/07/202308:00GLOBEDaré Bioscience Announces FDA Clearance of Investigational..
12/04/202308:00GLOBEDaré Bioscience Announces Commencement of Phase 3 Study of..
11/20/202308:00GLOBEDaré Bioscience and Premier Research Extend Strategic..
11/13/202308:00GLOBEDaré Bioscience to Present at the Sexual Medicine Society of..
11/09/202317:15EDGAR2Form 8-K - Current report
11/09/202316:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202308:05EDGAR2Form 8-K - Current report
11/09/202308:00GLOBEDaré Bioscience Reports Third Quarter 2023 Financial Results..
11/06/202308:00GLOBEDaré Bioscience to Participate in Three November Conferences
11/02/202308:00GLOBEDaré Bioscience to Host Third Quarter 2023 Financial Results..
11/01/202308:05EDGAR2Form 8-K - Current report
11/01/202308:00GLOBEDaré Bioscience Announces Additional Positive Data from..
10/16/202308:15EDGAR2Form 8-K - Current report
10/16/202308:00GLOBEDaré Bioscience Announces Achievement of First Commercial..
9/21/202308:00GLOBEDaré Bioscience Announces Grant Funding Installment to..
9/20/202308:00GLOBEDaré Bioscience to Present at The Menopause Society 2023..
9/11/202308:15EDGAR2Form 8-K - Current report
9/06/202308:00GLOBEDaré Bioscience to Participate in Upcoming Investor..
9/05/202308:00GLOBEDaré Bioscience Completes Previously Announced Equity..
8/30/202317:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
8/30/202316:05EDGAR2Form 8-K - Current report
8/30/202308:00GLOBEDaré Bioscience Announces $7.0 Million Registered Direct..
8/10/202316:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202308:05EDGAR2Form 8-K - Current report
8/10/202308:00GLOBEDaré Bioscience Reports Second Quarter 2023 Financial..
8/09/202308:00GLOBEDaré Bioscience Announces Publication in The Journal of The..
8/03/202308:00GLOBEDaré Bioscience to Host Second Quarter 2023 Financial..
7/31/202308:00GLOBEDaré Bioscience Announces Grant Award Supporting Development..
7/21/202316:01EDGAR2Form 8-K - Current report
7/11/202317:30GLOBEDaré Bioscience to Present at the 9th Annual International..
7/11/202308:00GLOBEDaré Bioscience Announces Additional Positive Data from..

Your Recent History

Delayed Upgrade Clock